Hannah D. McManus

Also affiliated with Duke Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma”.

Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad036

N/A

0.658DataRank · unranked

13 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.8747

N/A

0.208DataRank · unranked

3 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Lisa P. Spees, Michael E. Hurwitz +5 more

Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae067

N/A

0.104DataRank · unranked

1 citations

Jessica B. Long, Sarah J. Westvold, Khushi Agnish, Hannah D. McManus, Michael Leapman +6 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0.104DataRank · unranked

1 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.610

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.28

N/A

0DataRank · unranked

2 citations

Jessica B. Long, Sarah J. Westvold, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer(2025)10.1016/j.clgc.2025.102330

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Michael E. Hurwitz, Aaron Philip Mitchell +4 more